300357.SZ
300357.SZ
CNE100001R58
WOLWO PHARMA
Loading chart...

Company Profile

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of diagnostic and therapeutic products for allergic diseases in China and internationally. The company offers Changdi, a skin prick test product and dust mite drops; Changhao, an Artemisia annua pollen allergen sublingual drop; and Changdian, a dust mite skin prick test diagnostic kit. It is also involved in the research and development of cells and natural medicines. The company was founded in 2002 and is headquartered in Huzhou, China.

Related stocks

002019.SZ
002019.SZ • China
YIFAN PHARM
9.66 CNY
1.76B USD 1Y -30.7%
300181.SZ
300181.SZ • China
ZUO LI YAO YE
13.25 CNY
1.39B USD 1Y -25.8%
600771.SS
600771.SS • China
GUANGYUYUAN CHINESE HERBAL MEDI
14.38 CNY
1.05B USD 1Y -24.5%
600713.SS
600713.SS • China
NANJING PHARMACEUTICAL GP CO LT
5.14 CNY
1.01B USD 1Y +3.6%
RUBICON.NS
RUBICON.NS • India
RUBICON RESEARCH LIMITED
1,548.5 INR
2.65B USD
PFIZER.NS
PFIZER.NS • India
PFIZER LTD
3,808.2 INR
1.8B USD 1Y -27.7%
H02.SI
H02.SI • Singapore
Haw Par
12.77 SGD
2.21B USD 1Y -13.6%
4536.T
4536.T • Japan
SANTEN PHARMACEUTICAL CO
1,684 JPY
3.42B USD 1Y +7.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
43.0% p.a.
Max Drawdown (5Y)
-72.5%
Sharpe Ratio (5Y)
-0.51
Beta Factor
0.42
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (43.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.3% in the extended horizon.
ende